| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.63B | 2.44B | 2.95B | 1.80B | 2.25B | 1.92B |
| Gross Profit | 583.00M | 580.00M | 833.00M | 799.00M | 854.00M | 909.00M |
| EBITDA | 685.00M | 278.00M | 716.00M | 41.00M | 648.00M | 1.11B |
| Net Income | 386.00M | 68.00M | -805.00M | -165.00M | 906.00M | 901.00M |
Balance Sheet | ||||||
| Total Assets | 14.49B | 15.08B | 15.56B | 17.15B | 17.38B | 16.15B |
| Cash, Cash Equivalents and Short-Term Investments | 126.00M | 236.00M | 335.00M | 122.00M | 558.00M | 117.00M |
| Total Debt | 4.02B | 4.54B | 4.48B | 4.54B | 4.29B | 3.99B |
| Total Liabilities | 5.31B | 6.02B | 6.21B | 6.59B | 6.18B | 5.49B |
| Stockholders Equity | 9.19B | 9.05B | 9.35B | 10.56B | 11.13B | 10.59B |
Cash Flow | ||||||
| Free Cash Flow | 648.00M | 548.00M | 540.00M | -62.00M | 888.00M | 630.00M |
| Operating Cash Flow | 649.00M | 550.00M | 542.00M | -57.00M | 896.00M | 635.00M |
| Investing Cash Flow | 245.00M | -155.00M | 126.00M | -315.00M | -436.00M | -492.00M |
| Financing Cash Flow | -844.00M | -494.00M | -455.00M | -64.00M | -19.00M | -350.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | AU$17.79B | 12.29 | 9.54% | 4.13% | 5.44% | 231.88% | |
74 Outperform | AU$953.75M | 6.08 | 4.86% | 5.18% | ― | ― | |
70 Outperform | AU$8.79B | 10.60 | 19.38% | 1.97% | 15.06% | 47.66% | |
69 Neutral | AU$8.66B | 10.58 | 7.84% | 4.41% | 12.66% | ― | |
66 Neutral | AU$7.04B | 6.34 | 4.23% | 4.39% | -18.48% | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | AU$51.16B | 19.16 | 7.19% | 1.02% | 16.87% | ― |
Mirvac Group has announced that Non-Executive Director Christine Bartlett will resign from the Board effective 30 April 2026, after serving since December 2014 and leading the Human Resources Committee for the past five years. The Board and its chair, Rob Sindel, praised Bartlett’s significant contribution during a period of considerable change and growth, highlighting her experience, insight and governance leadership.
As part of its ongoing board renewal program, Mirvac will transition the chairmanship of its Human Resources Committee to current director Rosemary Hartnett from 1 May 2026, ensuring continuity in oversight of people and culture. The move underscores Mirvac’s focus on maintaining an appropriate mix of skills and perspectives at board level, which is particularly important as the diversified property group navigates its substantial development pipeline and evolving market conditions.
The most recent analyst rating on (AU:MGR) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on Mirvac Group stock, see the AU:MGR Stock Forecast page.
Mirvac Group has disclosed a change in director Campbell John Hanan’s interests in the company’s stapled securities, as required under ASX listing rules. The filing shows that Hanan holds his interests both directly and indirectly through related entities.
According to the notice, an associated entity of Hanan acquired 50,000 Mirvac stapled securities on market at $1.825 per security on 9 March 2026. Following this transaction, Hanan’s indirect holdings increased while his direct stapled security position remained nil, and his performance rights balance was unchanged, providing investors with updated transparency on executive alignment with shareholders.
The most recent analyst rating on (AU:MGR) stock is a Hold with a A$2.17 price target. To see the full list of analyst forecasts on Mirvac Group stock, see the AU:MGR Stock Forecast page.
Mirvac Group has notified the market of a change to its issued capital, following the lapse of 354,995 MGRAK long-term incentive performance rights. The rights ceased on 31 January 2026 because the performance or vesting conditions were not met, or could no longer be satisfied, resulting in no new securities being issued under this tranche.
The cessation of these performance rights effectively reduces the pool of potential equity that could have been created under Mirvac’s long-term incentive arrangements. This outcome may modestly limit prospective dilution for existing security holders and reflects performance outcomes relative to the hurdles attached to this specific incentive grant.
The most recent analyst rating on (AU:MGR) stock is a Hold with a A$2.17 price target. To see the full list of analyst forecasts on Mirvac Group stock, see the AU:MGR Stock Forecast page.
Mirvac Group has reported a change in the interests of non-executive director Rosemary Beryl Hartnett, reflecting an on-market purchase of additional stapled securities. Hartnett acquired 7,500 Mirvac stapled securities at $1.9995 each, increasing her direct holding from 56,111 to 63,611 securities, with no associated rights to acquire further stapled securities.
The transaction was conducted as an on-market trade and did not occur during a closed period, meaning no prior trading clearance was required under the company’s governance framework. The purchase signals increased personal exposure by a board member to Mirvac’s equity, a move that may be interpreted by investors as a sign of confidence in the group’s outlook and alignment with shareholder interests.
The most recent analyst rating on (AU:MGR) stock is a Hold with a A$2.17 price target. To see the full list of analyst forecasts on Mirvac Group stock, see the AU:MGR Stock Forecast page.
Mirvac Group has disclosed a change in director Damien John Frawley’s holding, following an on-market purchase of additional stapled securities. Frawley acquired 2,000 ordinary stapled securities at $1.97 each on 23 February 2026, increasing his direct interest from 88,415 to 90,415 stapled securities.
The transaction, executed through Stonehouse Pastoral Company Pty Ltd under the Frawley Family account, represents a modest increase in the director’s equity exposure to Mirvac. The company confirmed the trade did not occur during a closed period requiring prior written clearance, indicating the purchase was conducted under normal trading conditions.
The most recent analyst rating on (AU:MGR) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on Mirvac Group stock, see the AU:MGR Stock Forecast page.
Mirvac Group has notified the market of the cessation of 249,987 MGRAK LTP performance rights, which lapsed on 31 December 2025 after the conditions attached to those rights were not met or became incapable of being satisfied. The lapsing of these long-term incentive performance rights reflects a reduction in potential equity issuance under Mirvac’s incentive arrangements, modestly affecting its issued capital structure and signalling that certain performance hurdles linked to these rights were not achieved.
The most recent analyst rating on (AU:MGR) stock is a Sell with a A$2.00 price target. To see the full list of analyst forecasts on Mirvac Group stock, see the AU:MGR Stock Forecast page.
Mirvac Group has notified the market of the cessation of 38,716 LTP performance rights (ASX code MGRAK) following the lapse of conditional rights that could not be satisfied as of 30 November 2025. The lapse reduces the pool of potential equity-based remuneration tied to these long-term performance incentives, marginally affecting Mirvac’s issued capital structure and reflecting performance or condition outcomes linked to this tranche of rights.
The most recent analyst rating on (AU:MGR) stock is a Buy with a A$2.55 price target. To see the full list of analyst forecasts on Mirvac Group stock, see the AU:MGR Stock Forecast page.